Reducing Insulin Related Errors in Patients Treated for Hyperkalemia



Similar documents
CONGESTIVE HEART FAILURE PATIENT TEACHING

Provision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine

ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol

ROYAL HOSPITAL FOR WOMEN

BEAUMONT HOSPITAL DEPARTMENT OF NEPHROLOGY RENAL BIOPSY

Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes

ONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Specialty Scenarios MED-SURG

Hypoglycemia (Technician-Paramedic) Protocol revised October 2008

Rapid Response Report NPSA/2010/RRR013: Safer administration of insulin

GESTATIONAL DIABETES (DIET/INSULIN/METFORMIN) CARE OF WOMEN IN BIRTHING SUITE

PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS

Crash Cart Drugs Drugs used in CPR. Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University

Guideline for the Management of Acute Hyperkalaemia in Adults

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

Double pumping of intravenous vasoactive drugs in the critical care setting.

Humulin R (U500) insulin: Prescribing Guidance

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

3/26/2015. Debby Kasper, RDN, LDN Director, clinical nutrition Premier, Inc. Cathie Gosnell, RN, MS, MBA Clinical consultant Premier Safety Institute

Diabetic Ketoacidosis

SARASOTA MEMORIAL HOSPITAL

Hyperosmolar Non-Ketotic Diabetic State (HONK)

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

Insulin Treatment. J A O Hare. Bones, Brains & Blood Vessels

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

Introduction. Background to this event. Raising awareness 09/11/2015

Upstate University Health System Medication Exam - Version A

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins)

Anchor Bay School District Diabetic Medical Care Plan. Student Name Date Grade Teacher

Note that the following document is copyright, details of which are provided on the next page.

Clinical Guideline Diabetes management during surgery (adults)

at The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012

X-Plain Diabetes - Introduction Reference Summary

Learning from Defects

User guide Basal-bolus Insulin Dosing Chart: Adult

Electronic Medication Administration Record (emar) (For Cerner Sites Only)

INTRAVENOUS FLUIDS. Acknowledgement. Background. Starship Children s Health Clinical Guideline

Analysis One Code Desc. Transaction Amount. Fiscal Period

SECTION: NM NUMBER: 20. HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs

Diabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Continuous Quality Improvement using Centricity EMR

Southern Derbyshire Shared Care Pathology Guidelines. Hyperkalaemia

Unstoppable Report Removing a Barrier to Patient Flow by Nursing Process Redesign

CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications

Safe use of insulin e- learning module

Electronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with)

Objective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011

Reducing harm from high-alert medications

CARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy

IN-HOME QUALITY IMPROVEMENT BEST PRACTICE: PHYSICIAN RELATIONSHIPS NURSE TRACK

SHINE Study Ordering Instructions for Investigators SUNY Downstate

The New Complex Patient. of Diabetes Clinical Programming

Drug Calculations. How to Solve Drug Calculations

HEALTH MANAGEMENT PLAN PROGRAMME

Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I

Replacement post-filter (ml/hr) Blood flow (ml/min) Dialysate (ml/hr) Weight (kg)

Medicare Drug Coverage Under Part A, Part B, and Part D

D( desired ) Q( quantity) X ( amount ) H( have)

DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES

[ ] POCT glucose Routine, As needed, If long acting insulin is given and patient NPO, do POCT glucose every 2 hours until patient eats.

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

Case 2:08-cv ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138. Exhibit 8

University of Gezira. Faculty of Medicine. Department of Paediatrics and Child Health. Integrated Management of Diabetes in Children (IMDC) Project

Medications or therapeutic solutions may be injected directly into the bloodstream

CHESHIRE EAST COUNCIL DRIVER MEDICAL

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Managing the Hospitalized Patient on Insulin: Care Transition. Catie Prinzing MSN, APRN, CNS

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures

A Guide to Starting. Humalog Mix25

SLIDING SCALE INSULIN ASPART PROTOCOL PLAN

ARIZONA INTRASTATE DIABETES WAIVER PROGRAM

What Is Patient Safety?

Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE

Diabetes mellitus. Lecture Outline

ENROLLED NURSE GRADUATE PROGRAM: BENDIGO HEALTH. Dr Helen Aikman Manager of Nursing and Midwifery Education

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment

Management of Diabetes Mellitus in Custody

BEHAVIORAL HEALTH AND DETOXIFICATION - MEETING DEMAND FOR SERVICES UNIVERSITY OF PITTSBURGH MEDICAL CENTER MERCY HOSPITAL Publication Year: 2013

INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco

Procedure for Inotrope Administration in the home

Skills Standards ADVANCED CMA: INSULIN ADMINISTRATION OD68609 MEETS OSDH NURSE AIDE REGISTRY CERTIFICATION REQUIREMENTS

Patient Care Services Quality Report Evaluation of 2013 Outcomes August 2014

Should Insulin be added to Parenteral Nutrition?

Cardiac Arrest - Ventricular Fibrillation / Pulseless Ventricular Tachycardia Protocol revised October 2008

Transcription:

Reducing Insulin Related Errors in Patients Treated for Hyperkalemia Tan Tock Seng Hospital is an acute care general hospital with a 1,200 bed capacity The hospital addressed the problem of insulinrelated errors in patients treated for hyperkalemia using the Clinical Process Improvement Project (CPIP) methodology We wish to share their innovative solution of using a HIGH-K + pack to deal with this problem

Mission Statement All cases of hyperkalemia (serum K + > 6mmol/L) should have appropriate* Treatment Monitoring instituted within six hours of notification of hyperkalemia Time frame for implementation of project: Within 6 months

Appropriate Treatment To be started within an hour of hyperkalemia notification Correct indication (rule out pseudo-hyperkalemia) ECG and baseline capillary blood glucose(cbg) taken Stop all medications causing hyperkalemia IV Calcium Gluconate (ECG changes + Serum K + > 6.5mmol/L) IV Insulin 5-10 units + IV Dextrose Resonium IV Frusemide, if indicated

Appropriate Monitoring To be started within an hour of hyperkalemia notification Need for Telemetry or High Dependency stay (Serum K + >7 + ECG changes + muscle weakness + rising K + levels/other medical indication), Baseline CBG Hourly CBG for 6 hours after IV Insulin bolus Repeat ECG within 1 hour if ECG changes Repeat K + in 2 hours if ECG changes Repeat ECG in 4-6 hours if ECG normal Repeat K + in 4-6 hours if ECG normal Maintenance IV Dextrose infusion started if indicated

Team Members Team Leader Dr Julie George, Consultant, General Medicine Expert advisors Dr Alvin Tan, Consultant, Endocrinology Dr Jackie Tan, Head of Department, General Medicine Team Members Dr Aisah F, Medical Officer Dr Joel Lim, Resident, Dr Goh W Y, Resident, Sr Rusvinder Kaur, Nurse Clinician Ms Lim Chee Yuen, Pharmacist Ms Irene, SN, Ms Nor, SN

Evidence for Problem Worth Solving Sentinel Events Case 1 77-year-old Chinese male with history of hypertension, hyperlipidemia, Ischemic Heart Disease(IHD), peptic ulcer disease and renal impairment was admitted, via Emergency Department, with complaints of shortness of breath and bilateral lower limb weakness Patient was assessed as having an acute chronic renal failure and worsening IHD He was prescribed IV insulin 10 units in 40 ml Dextrose 50% solution House Officer (HO) inadvertently administered 100 units of insulin in 20 ml Dextrose 50% solution Patient was found unresponsive and glucometer showed patient was hypoglycemic He subsequently developed aspiration pneumonia secondary to coma and died

Evidence for Problem Worth Solving Sentinel Events.Case 2 House Officer administered IV insulin to patient as part of the management for hyperkalemia 60 units of insulin rather than the intended 6 units was administered as he assumed that 1unit of Insulin was equivalent to 1 large marking (5 small markings) on the insulin syringe

Evidence for Problem Worth Solving Sentinel Events.Case 3 Patient admitted for gastroenteritis associated with hyperkalemia He was prescribed 10 units of Insulin but the House Officer used a normal syringe and administered 8 mls on Insulin (equivalent to 800 units!) instead Patient developed hypoglycemia and was transferred to ICU but subsequently recovered

Evidence for Problem Worth Solving Sentinel Events.Case 4 Patient was admitted for treatment of hyperkalemia 8 units of Insulin were ordered House Officer drew the insulin into a 3ml syringe and administered entire volume of 3 ml to the patient intravenously Patient received 300 units instead of 8 units of Insulin!! She had 5 episodes of hypoglycemia which was treated with IV 50% Fortunately she recovered

Why Do Insulin-Related Errors Occur? Errors in Insulin Dosage Use of regular syringe to administer insulin Unfamiliarity with unit markings on insulin syringe Failure to monitor glucose levels following administration of insulin

Baseline data Baseline data of medical patients admitted in Nov 2010 and Jan 2011 for hyperkalemia: Total no of cases requiring insulin to correct hyperkalemia: 28 cases % of cases that received appropriate treatment: 78% % of cases that were monitored for hypoglycemia: 7%

Reasons for Inadequate Treatment & Monitoring of Patients with Hyperkalemia Protocol No existing protocol on treatment and monitoring of patients with hyperkalemia Training and Orientation No formal training and orientation for junior doctors on management of hyperkalemia Knowledge deficit Junior doctors were not familiar with insulin syringes and markings on insulin syringes

Interventions CAUSE INTERVENTIONS DATE OF IMPLEMENTATION No Protocol for Hyperkalemia Management Flow chart on acute management and monitoring of patients with hyperkalemia developed and placed in HIGH K + pack. Use of a stamp to assist nurses in documentation and monitoring needs of patients on treatment for hyperkalemia. 22 nd March 2011 3 rd May 2011 Lack of Training and Orientation Knowledge Deficit about Insulin Syringes Briefing for all Doctors and Nurses on Protocol for hyperkalemia management Training for all Doctors on use of Insulin syringes High K + pack Regular Insulin with tag to remind users to use insulin syringe. High K + pack stocked with insulin syringe. Regular Insulin with picture to show how dose should be drawn. 1 st March 2011 22 nd March 2011

Hyperkalemia Pack Hyperkalemia protocol Table of content Alcohol swabs Actrapid vial (tagged) Monitoring stamp Insulin syringes

Each Actrapid vial tagged

New Protocol for Treatment and Monitoring of Patients with Hyperkalemia New Protocol for treatment and management of hyperkalaemia S.K> 6mmol/L Hyperkaleamia Exclude pseudohyperkalaemia E.g. Hemolysis Repeat S. K Treatment Monitoring ECG + */ S.K >6.5 High risk patients: Acute renal failure/ ESRF on dialysis/ Coronary Artery Disease/ Acute Myocardial Injury 1.IV Calcium Gluconate 10 ml of 10% over 2-3 minutes ( slow infusion over 20 mins in 100mls of 5%Dextrose in patients on digoxin) Telemetry/bedside cardiac monitor/ hourly parameters( based on availability) or High Dependency monitoring if patient is unstable ECG, HC (Capillary blood ECG n/ S.K <6.5 glucose) 2.IV Insulin Regular 5-10 units + IV Dextrose 50% 40 mls bolus (Dextrose could be avoided if baseline HC>18mmol/L) Consider maintenance IV dextrose infusion* (if baseline HC <6 /NBM /Poor oral intake/ previous episodes of hypoglycemia*) 3.Resonium (PO 15-30 gm or PR 30 gm) 4.Stop all IV/oral medications causing hyperkalaemia* 5.HC hourly for 6 hours Hourly parameters *Refer to details in medicine bulletin board Copyright TTSH, 2011 Repeat ECG in 10 mins to check for ECG resolution and at 30min-1 hour in patients who are not on telemetry Repeat dose of IV Calcium gluconate if ECG changes are persistent Telemetry/High dependency needed Repeat S.K+in 2 hours Repeat S.K+ and ECG in 4-6 hours Persistent hyperkalaemia 1.Repeat steps 1-5 2.Consider IV Lasix ( with residual renal function) /Ventolin nebulisation* /dialysis*

Monitoring Stamp for Patients with Hyperkalemia Date: Time: Monitoring Stamp: To be signed by doctor managing the patient Telemetry or HD or hourly monitoring of vital signs Baseline CBG before IV Insulin bolus Hourly CBG for 6 hours after IV insulin bolus If ECG changes present: o Repeat ECG in 1 hour o Repeat K+ in 2 hours If ECG normal: o Repeat ECG in 4-6 hours o Repeat K+ in 4-6 hours Tick as appropriate Maintenance drip as indicated IV 5%Dextrose or IV Dextrose-Saline

Outcome Measures Treatment & Monitoring of Patients with Hyperkalemia Education Protocol, High K pack Monitoring stamp, education Reinforcement 100 80 60 88 Mean: 92.5 74 100 100 93 53 100 86 60 61 100 100 Men: 97.7 79 73 % Compliance 40 20 0 11 5 0 25 Nov-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun11 Jul11 Aug11 Treatment Monitoring

Blood Glucose Monitoring Monitoring data Nov 2010 N=9 Jan 2011 N=19 Feb 2011 N=4 March 2011 N=8 April 2011 N=15 May 2011 N=10 June 2011 N=7 July 2011 N=14 Aug 2011 N=15 Blood glucose monitoring Incidence of Hypoglycemia (overall) (CBG < 4mmol/L) 33% 21% 0% 75% 60% 70% 85% 92% 87% 11% 4% 0% 0% 0% 30% 14% 7% 20%

Lessons Learned All patients on insulin are at-risk for hypoglycemia because of either errors in insulin dosage or the treatment per se All patients on insulin MUST be monitored for hypoglycemia Team was able to develop an innovative solution by working closely with people on the ground the House Officers and Nurses

Thank You!